ConductScience.org, home

Paper3065243

Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.

van Poppel H and 3 others. Infection, 1988. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review. Papers, record 3065243. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3065243

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Clinical experience with ciprofloxacin in the treatment of urinary tract infections: a review.
PubMed
Journal
Infection
PubMed
Year
1988
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.57
iCite
Revised in PubMed
2026-10-11
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1van Poppel HH
2Chyský VV
3Hullmann RR
4Baert LL

Source PubMed

Download CSV of authors

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CiprofloxacinMajor topic
Enterobacteriaceae InfectionsMajor topic
Urinary Tract InfectionsMajor topic
Adult
Aged
Bacteriuria
Female
Humans
Male
Microbial Sensitivity Tests
Middle Aged

Source PubMed

Download CSV of topics

References21

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
12941294Ciprofloxacin in the treatment of urinary tract infection in patients with multiple sclerosis.Eur J Clin Microbiol1986https://conductscience.org/library/papers/2941294PubMed
23555042Double-blind comparison of ciprofloxacin with cefotaxime in the treatment of skin and skin structure infections.Am J Med1987https://conductscience.org/library/papers/3555042PubMed
33542946The mode of action of 4-quinolones and possible mechanisms of resistance.J Antimicrob Chemother1986https://conductscience.org/library/papers/3542946PubMed
42933381Efficacy and safety of ciprofloxacin (Bay 0 9867) in the treatment of patients with complicated urinary tract infections.J Antimicrob Chemother1985https://conductscience.org/library/papers/2933381PubMed
53542943Ciprofloxacin therapy in complicated urinary tract infections caused by Pseudomonas aeruginosa and other resistant bacteria.J Antimicrob Chemother1986https://conductscience.org/library/papers/3542943PubMed
66228192In vitro activity of ciprofloxacin (Bay o 9867).Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6228192PubMed
73804903Treatment of skin and soft tissue infections with oral ciprofloxacin.J Antimicrob Chemother1986https://conductscience.org/library/papers/3804903PubMed
83804900The efficacy and safety of ciprofloxacin in the treatment of chronic Pseudomonas aeruginosa urinary tract infection.J Antimicrob Chemother1986https://conductscience.org/library/papers/3804900PubMed
96237904Mutational resistance to 4-quinolone antibacterial agents.Eur J Clin Microbiol1984https://conductscience.org/library/papers/6237904PubMed
103492486Comparison of ciprofloxacin and co-trimoxazole in the treatment of uncomplicated urinary tract infection in women.J Antimicrob Chemother1986https://conductscience.org/library/papers/3492486PubMed
113013631Overview of clinical experience with ciprofloxacin.Eur J Clin Microbiol1986https://conductscience.org/library/papers/3013631PubMed
122941286Clinical experience with ciprofloxacin in the USA.Eur J Clin Microbiol1986https://conductscience.org/library/papers/2941286PubMed
1316312452Biotyping and susceptibility behaviour of pathogens in patients treated with ciprofloxacin.J Chemother1989https://conductscience.org/library/papers/16312452PubMed
143542942A comparative study of ciprofloxacin and trimethoprim in the treatment of urinary tract infections in geriatric patients.J Antimicrob Chemother1986https://conductscience.org/library/papers/3542942PubMed
153468100The comparative in-vitro activity of eight newer quinolones and nalidixic acid.J Antimicrob Chemother1986https://conductscience.org/library/papers/3468100PubMed
163100490Ciprofloxacin in the treatment of Pseudomonas infection in cystic fibrosis patients.J Antimicrob Chemother1986https://conductscience.org/library/papers/3100490PubMed
176222695In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.Antimicrob Agents Chemother1983https://conductscience.org/library/papers/6222695PubMed
182941288Evaluation of ciprofloxacin in the treatment of Pseudomonas aeruginosa infections.Eur J Clin Microbiol1986https://conductscience.org/library/papers/2941288PubMed
193325932Treatment of multi-resistant urinary tract infections in patients with multiple sclerosis.Pharm Weekbl Sci1987https://conductscience.org/library/papers/3325932PubMed
202936583Oral treatment of Pseudomonas-induced urinary tract infections with ciprofloxacin.Chemotherapy1986https://conductscience.org/library/papers/2936583PubMed

See all 21 referencesDownload CSV of references

Cited by5

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
26848334Susceptibility pattern of uropathogens to ciprofloxacin at the Ghana police hospital.Pan Afr Med J2015https://conductscience.org/library/papers/26848334PubMed
21984270Susceptibility of Pseudomonas aeruginosa urinary tract isolates and influence of urinary tract conditions on antibiotic tolerance.Curr Microbiol2012https://conductscience.org/library/papers/21984270PubMed
16856014Quinolones for uncomplicated acute cystitis in women.Cochrane Database Syst Rev2006https://conductscience.org/library/papers/16856014PubMed
12843075Detection and identification of ciprofloxacin-resistant Yersinia pestis by denaturing high-performance liquid chromatography.J Clin Microbiol2003https://conductscience.org/library/papers/12843075PubMed
10146890Oral ciprofloxacin: a pharmacoeconomic evaluation of its use in the treatment of serious infections.Pharmacoeconomics1993https://conductscience.org/library/papers/10146890PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3065243

GET https://conductscience.org/api/papers/v1/3065243/references?page=2